Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

D. Hull, Russell; E. Raskob, Gary; F. Pineo, Graham; Green, David; A. Trowbridge, Arthur; Gregory Elliott, C.; G. Lerner, Robert; H. Hall, Jack; G. Sparling, Terence; R. Brettell, Herbert; A. Norton, John; J. Carter, Cedric; George, Ralph; J. Merli, Geno; Ward, John; Mayo, Warren; Rosenbloom, David; Brant, Rollin

doi:10.1056/nejm199204093261502

Public

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

Published in New England Journal of Medicine • Apr 9, 1992

Authors:

Russell D. Hull

Gary E. Raskob

Graham F. Pineo

Abstract

BACKGROUND: Low-molecular-weight heparin has a high bioavailability and a prolonged half-life in comparison with conventional unfractionated heparin. Limited data are available for low-molecular-weight heparin as compared with unfractionated heparin for the treatment of deep-vein thrombosis. METHODS...

Subject

Heparin

Medicine

Deep vein

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!